AJP - Renal Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Renal Physiol 261: F512-F518, 1991;
0363-6127/91 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gibson, R. E.
Right arrow Articles by Siegl, P. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gibson, R. E.
Right arrow Articles by Siegl, P. K.

AJP - Renal Physiology, Vol 261, Issue 3 512-F518, Copyright © 1991 by American Physiological Society

ARTICLES

Angiotensin II receptor subtypes in renal cortex of rats and rhesus monkeys

R. E. Gibson, H. H. Thorpe, M. E. Cartwright, J. D. Frank, T. W. Schorn, P. B. Bunting and P. K. Siegl
Department of Radiopharmacology, Merck Sharp & Dohme Research Laboratories, West Point, Pennsylvania 19486.

The angiotensin II (ANG II) receptor has recently been shown to exhibit subtypes with respect to antagonist binding. Of particular interest are the potent nonpeptide antagonists, DUP 753 and PD 121981, which exhibit selectivity for the subtype 1 (AT1) and subtype 2 (AT2) receptors, respectively. We used these high-affinity antagonists in competition with 125I-[Sar1,Ile8]ANG II to determine autoradiographically the distribution of these ANG II-receptor subtypes in the renal cortex of rats and rhesus monkeys. Binding of the radioligand to receptor in sections of rat renal cortex was inhibited by DUP 753; inhibition by PD 121981 was not detected. By contrast, AT1 and AT2 receptors are present in the renal cortex of rhesus monkeys in regionally distinct structures. DUP 753 inhibited binding to the ANG II receptor in glomeruli. PD 121981 inhibited binding to arterial smooth muscle and the juxtaglomerular (JG) apparatus. The JG apparatus also exhibits radioligand binding, which is inhibited by DUP 753. The effect of DUP 753 and PD 123177 (a more water-soluble analogue of PD 121981) on changes in plasma renin activity was examined to determine if one or both of these subtypes participate in the ANG II-mediated negative feedback of control of renin release. Although DUP 753 increased plasma renin activity to the same extent as the angiotensin-converting enzyme inhibitor, enalaprilat, in rats and rhesus monkeys, the AT2 antagonists did not affect renin release in either species. Thus both subtypes of ANG II receptor are present in rhesus monkey cortex, but a function for only the AT1 subtype was demonstrated.


This article has been cited by other articles:


Home page
 Am. J. Physiol. Renal Physiol.Home page
S. P. Bagby, L. S. LeBard, Z. Luo, B. E. Ogden, C. Corless, E. D. McPherson, and R. C. Speth
ANG II AT1 and AT2 receptors in developing kidney of normal microswine
Am J Physiol Renal Physiol, October 1, 2002; 283(4): F755 - F764.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
Z. SZABO, R. C. SPETH, P. R. BROWN, L. KERENYI, P. F. KAO, W. B. MATHEWS, H. T. RAVERT, J. HILTON, P. RAUSEO, R. F. DANNALS, et al.
Use of Positron Emission Tomography to Study AT1 Receptor Regulation In Vivo
J. Am. Soc. Nephrol., July 1, 2001; 12(7): 1350 - 1358.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
J. M. Saavedra, W. Hauser, G. Ciuffo, G. Egidy, K.-L. Hoe, O. Johren, T. Sembonmatsu, T. Inagami, and I. Armando
Increased AT1 receptor expression and mRNA in kidney glomeruli of AT2 receptor gene-disrupted mice
Am J Physiol Renal Physiol, January 1, 2001; 280(1): F71 - F78.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
M. de Gasparo, K. J. Catt, T. Inagami, J. W. Wright, and Th. Unger
International Union of Pharmacology. XXIII. The Angiotensin II Receptors
Pharmacol. Rev., September 1, 2000; 52(3): 415 - 472.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
S. MYOU, M. FUJIMURA, Y. KAMIO, Y. ISHIURA, K. KURASHIMA, H. TACHIBANA, T. HIROSE, and T. HASHIMOTO
Effect of Losartan, a Type 1 Angiotensin II Receptor Antagonist, on Bronchial Hyperresponsiveness to Methacholine in Patients with Bronchial Asthma
Am. J. Respir. Crit. Care Med., July 1, 2000; 162(1): 40 - 44.
[Abstract] [Full Text]

Home page
 Circ. Res.Home page
H. Matsubara
Pathophysiological Role of Angiotensin II Type 2 Receptor in Cardiovascular and Renal Diseases
Circ. Res., December 14, 1998; 83(12): 1182 - 1191.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
L. S. Jacobs and J. G. Douglas
Angiotensin II Type 2 Receptor Subtype Mediates Phospholipase A2–Dependent Signaling in Rabbit Proximal Tubular Epithelial Cells
Hypertension, October 1, 1996; 28(4): 663 - 668.
[Abstract] [Full Text]

Home page
 HypertensionHome page
N. Bouby, L. Bankir, and C. Llorens-Cortes
Type 1 Angiotensin II Receptor Subtypes in Kidney of Normal and Salt-Sensitive Hypertensive Rats
Hypertension, March 1, 1996; 27(3): 392 - 398.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online